Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies
Journal
Annals of Clinical and Translational Neurology
Publication Date
3-1-2021
Volume
8
Issue
3
First Page
571
Last Page
578
Document Type
Open Access Publication
DOI
10.1002/acn3.51294
Rights and Permissions
Ikenaga, C., Findlay, A.R., Goyal, N.A., Robinson, S., Cauchi, J., Hussain, Y., Wang, L.H., Kershen, J.C., Beson, B.A., Wallendorf, M., Bucelli, R.C., Mozaffar, T., Pestronk, A. and Weihl, C.C. (2021), Clinical utility of anti-cytosolic 5’-nucleotidase 1A antibody in idiopathic inflammatory myopathies. Ann. Clin. Transl. Neurol., 8: 571-578. https://doi.org/10.1002/acn3.51294 © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Ikenaga, Chiseko; Findlay, Andrew R; Goyal, Namita A; Robinson, Sarah; Cauchi, Jonathan; Hussain, Yessar; Wang, Leo H; Kershen, Joshua C; Beson, Brent A; Wallendorf, Michael; Bucelli, Robert C; Mozaffar, Tahseen; Pestronk, Alan; and Weihl, Conrad C, "Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies." Annals of Clinical and Translational Neurology. 8, 3. 571 - 578. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11293
Figure S1 and Tables S1-S3